What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.46%Below 5Y avg (1.29%)
Annual Rate
CNY 0.05Paid annual
Payout Ratio
61.6%Moderate
Last Ex-Dividend
Nov 26, 2025
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.89BCNY
518.77M · vs all stocks (USD)
Updated Nov 22, 2026
Revenue (TTM)
1.05BCNY
156.72M · vs all stocks (USD)
Updated Nov 22, 2026
Profit Margin
-6.32%
vs Medical Devices peers
Updated Nov 22, 2026
Beta
0.6790x
vs all stocks
Updated Nov 22, 2026
52-Week Change
27.30%
vs all stocks
Updated Nov 22, 2026
Market Capitalization
2.89BCNY
518.77M · vs all stocks (USD)
Updated Nov 22, 2026
Enterprise Value
3.04BCNY
524.24M · vs all stocks (USD)
Updated Nov 22, 2026
Forward P/E
16.04x
vs Medical Devices peers
Updated Nov 22, 2026
Price to Sales (TTM)
2.76x
vs Medical Devices peers
Updated Nov 22, 2026
Price to Book (MRQ)
2.64x
vs Medical Devices peers
Updated Nov 22, 2026
Enterprise to Revenue
2.90x
vs Medical Devices peers
Updated Nov 22, 2026
Gross Margin
22.02%
vs Medical Devices peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 24.77%.Updated Nov 22, 2026
Profit Margin
-6.32%
vs Medical Devices peers
Updated Nov 22, 2026
Operating Margin
-6.49%
vs Medical Devices peers
Updated Nov 22, 2026
Return on Assets (TTM)
-1.69%
vs Medical Devices peers
Updated Nov 22, 2026
Return on Equity (TTM)
-4.76%
vs Medical Devices peers
Updated Nov 22, 2026
Revenue (TTM)
1.05BCNY
156.72M · vs all stocks (USD)
Updated Nov 22, 2026
Revenue per Share (TTM)
3.96CNYUpdated Nov 22, 2026
Quarterly Revenue Growth
10.40%
vs Medical Devices peers
Updated Nov 22, 2026
Gross Profit (TTM)
259.19MCNY
38.83M · vs all stocks (USD)
Updated Nov 22, 2026
EBITDA (TTM)
60.34MCNY
9.04M · vs all stocks (USD)
Updated Nov 22, 2026
Net Income (TTM)
-66.14MCNY
-9.91M · vs all stocks (USD)
Updated Nov 22, 2026
Quarterly Earnings Growth (YoY)
10.90%
vs Medical Devices peers
Updated Nov 22, 2026
Operating Cash Flow (TTM)
68.65MCNY
10.28M · vs all stocks (USD)
Updated Nov 22, 2026
Levered Free Cash Flow (TTM)
72.42MCNY
11.90M · vs all stocks (USD)
Updated Nov 22, 2026
Trailing Annual Dividend Rate
0.0500CNYUpdated Nov 22, 2026
Trailing Annual Dividend Yield
0.46%
vs all stocks
Updated Nov 22, 2026
5-Year Average Dividend Yield
1.29%
vs all stocks
Updated Nov 22, 2026
Payout Ratio
61.60%
vs Medical Devices peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives -11.36%.Updated Nov 22, 2026
Minority Interest (Equity)
74.65MCNYFY2025 · Dec 31, 2025
Revenue
1.10BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
813.86MCNYFY2025 · Dec 31, 2025
Gross Profit
281.53MCNYFY2025 · Dec 31, 2025
Operating Income
-16.76MCNY
-2.51M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-76.30MCNYFY2025 · Dec 31, 2025
Income Tax Expense
-10.89MCNYFY2025 · Dec 31, 2025
Net Income
-65.41MCNYFY2025 · Dec 31, 2025
EBIT
-48.68MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
60.34MCNYFY2025 · Dec 31, 2025
Research & Development
69.68MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
111.51MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
7.88MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
13.94MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
27.62MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.2624CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.2624CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
264.59MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
264.59MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-65.41MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-4.02MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-287.44MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-442.25MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
661.80MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-65.41MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
42.87MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-186.80MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-78.11MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-154.81MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-89.00MCNYFY2025 · Dec 31, 2025
Sale of Investments
340.31MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
96.51MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
371.50MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-304.08MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-30.65MCNYFY2025 · Dec 31, 2025
Other Financing Charges
5.52MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
42.30MCNYFY2025 · Dec 31, 2025
Shares Outstanding
264.61MSharesUpdated Nov 22, 2026
Float Shares
184.47MSharesUpdated Nov 22, 2026
% Held by Insiders
32.81%
vs all stocks
Updated Nov 22, 2026
% Held by Institutions
1.96%
vs all stocks
Updated Nov 22, 2026
Total Cash (MRQ)
388.72MCNY
90.89M · vs all stocks (USD)
Updated Nov 22, 2026
Total Cash per Share (MRQ)
1.49CNYUpdated Nov 22, 2026
Total Debt (MRQ)
496.75MCNY
96.79M · vs all stocks (USD)
Updated Nov 22, 2026
Total Debt to Equity (MRQ)
0.4296x
vs Medical Devices peers
Updated Nov 22, 2026
Current Ratio (MRQ)
1.62x
vs Medical Devices peers
Updated Nov 22, 2026
Book Value per Share (MRQ)
4.14CNYUpdated Nov 22, 2026
Total Assets
2.52BCNY
377.84M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.28BCNYFY2025 · Dec 31, 2025
Total Liabilities
1.31BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
1.25BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
507.58MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
802.54MCNYFY2025 · Dec 31, 2025
Cash
665.61MCNYFY2025 · Dec 31, 2025
Cash Equivalents
11.34MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
676.95MCNYFY2025 · Dec 31, 2025
Accounts Receivable
242.14MCNYFY2025 · Dec 31, 2025
Inventory
287.82MCNYFY2025 · Dec 31, 2025
Accounts Payable
224.01MCNYFY2025 · Dec 31, 2025
Short-term Debt
397.60MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
9.31MCNYFY2025 · Dec 31, 2025
Long-term Debt
327.21MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
1.04MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
264.58MCNYFY2025 · Dec 31, 2025
Retained Earnings
352.77MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.21BCNY
181.59M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
20.01MCNYFY2025 · Dec 31, 2025
52-Week Low
7.67CNYUpdated Nov 22, 2026
52-Week High
21.98CNYUpdated Nov 22, 2026
52-Week Change
27.30%
vs all stocks
Updated Nov 22, 2026
Beta
0.6790x
vs all stocks
Updated Nov 22, 2026
50-Day MA
13.87CNYUpdated Nov 22, 2026
200-Day MA
15.53CNYUpdated Nov 22, 2026
Avg 10-Day Volume
5.22MSharesUpdated Nov 22, 2026
Avg 30-Day Volume
5.62MSharesUpdated Nov 22, 2026
Diluted EPS (TTM)
-0.4400CNYUpdated Nov 22, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 22%, lower than 95% of its Medical Devices peers (median 64.2%)Significant